The biotech industry is still one of the most progressive areas to invest in for those looking for opportunities in the healthcare sector. Companies continue to rival each other in coming up with the best treatments and vaccines. Research in the pharmaceuticals market will continue for eons because, after every question that is answered in the medical space, another one arises.
The concept of trying to identify which company will come up with a life-changing drug or treatment has overshadowed the impact of developments made in other segments of the healthcare sector, especially the medical technology market. According to a research article published by Ernst & Young last year, the US & European medical technology market is valued more than any of the top five stock indices in the two regions.
While most investors are well-informed about various drug manufacturers and the most promising drugs in the clinical pipelines of pharmaceutical companies, very few are aware of the developments taking place in the medical technology market.
The use of nano-crystals technology in the healthcare market has been around for a while, but significant developments have taken place over the last few years. Cell crystallization is potentially the pathway to finding a cure for some of the most notorious diseases that mankind has ever faced. Companies are using homogenizer technologies and wet milling to produce stable nano-particles that can be used to develop treatments for such diseases.
Companies are also investing heavily in wearable medical devices as they seek to personalize healthcare while some treatments require unique medical delivery technologies to administer to patients. In general, the medical technology industry is one of the largest markets in the healthcare sector and it continues to grow at incredible rates.
Investors looking to pounce on opportunities arising from the latest inventions in this space can benefit by investing in some of the top players which include Medtronic PLC (MDT), Abiomed (ABMD) and NuVasive (NUVA), among others.
